Inyx, Inc. (IYXI)

0.0001 0.0000 (0.00%) At close: 11:24AM EDT

Inyx, Inc.

825 Third Avenue
40th Floor
New York, NY 10022
United States
212-838-1111

Sector(s): 
Industry: 
Full Time Employees: 572

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Steven Handley	President & Director	200.57k	N/A	1964
Mr. Jay M. Green	Executive VP, Director of Corporate Development & Director	275k	N/A	1950
Ms. Carole Richardson	Corporate Administration Manager of Inyx Pharma Ltd.	N/A	N/A	N/A
Mr. William Kelly	Vice President of Corporate Communications & Investor Relations	N/A	N/A	N/A
Mr. Stephen Beckman	Vice President of Sales & Marketing and Commercial Development	N/A	N/A	1967

Amounts are as of December 31, 2003 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Inyx, Inc., through its wholly-owned subsidiaries, operates as a specialty pharmaceutical company in the United States, Canada, and Europe. It develops and manufactures prescription and over-the-counter pharmaceutical products. The company manufactures hydrocarbon aerosols, a delivery system for dermatological and topical drug applications; metered dose inhalers that are used for respiratory conditions; dry powdered inhalers used for respiratory ailments; metered dose nasal and throat pumps, and sprays; and sterile salines and injectables. It focuses on research and development activities on inhalation-therapy drug delivery devices and inhalation methods, and generic prescription, and over-the-counter aerosol pharmaceutical products for respiratory, allergy, dermatological, and topical and cardiovascular applications. The company's proprietary products under development include generic versions of nonchlorofluorocarbon or hydrofluoroalkane single molecule and combination drug respiratory inhalants, nonCFC propelled oral sprays for cardiovascular ailments, wound irrigation, and cleansing sprays that utilize novel barrier technologies, and anti-inflammatory nasal pumps. It also provides specialty pharmaceutical development and manufacturing consulting services to the international healthcare market. The company was incorporated in 2000 and is based in New York, New York.

Corporate Governance

Inyx, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.